
|Articles|April 5, 2011
Generic Drugs, Neuroimaging, Pharmacogenetic Approaches, and More
Author(s)Psychiatric Times Editors
Which neuroimaging technologies uses the motion of water molecules to investigate the microstructure and organization of white matter tracts in the brain? Which pharmacogenetic approaches might be used as a predictor of antipsychotic drug response? These questions and more in this quiz.
Advertisement
Which neuroimaging technologies uses the motion of water molecules to investigate the microstructure and organization of white matter tracts in the brain? Which pharmacogenetic approaches might be used as a predictor of antipsychotic drug response? These questions and more in this quiz.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Anticholinergic Burden and Its Effect on Cognition in Psychosis
4
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
5
















